Keyphrases
Amputation
12%
Clinical Examination
12%
Clinical Outcomes
12%
Clinical Response
25%
Effective Treatment
12%
Extremity Soft Tissue Sarcoma
100%
High Dose
25%
Hospital Stay
25%
Iliac
12%
Isolated Limb Perfusion
100%
Local Control
12%
Local Recurrence Rate
12%
Local Toxicity
25%
Magnetic Resonance Imaging
12%
Melphalan
25%
Pathological Response
12%
Perfusion
25%
Reduced Dose
12%
Response Evaluation
12%
Response Rate
12%
Single-center Experience
12%
Treatment Modalities
12%
Treatment Modification
100%
Treatment Options
12%
Treatment Results
12%
Tumor Necrosis Factor-α
100%
Two-period
12%
Nursing and Health Professions
Amputation
12%
Clinical Examination
12%
Clinical Outcome
12%
Drug Megadose
25%
Hospitalization
25%
Limb Perfusion
100%
Melphalan
25%
Nuclear Magnetic Resonance Imaging
12%
Perfusion
25%
Recurrence Risk
12%
Soft Tissue Sarcoma
100%
Tumor Necrosis
100%
Tumor Necrosis Factor
12%
Medicine and Dentistry
Amputation
12%
Clinical Examination
12%
Drug Megadose
25%
Limb
12%
Limb Perfusion
100%
Magnetic Resonance Imaging
12%
Melphalan
25%
Recurrence Risk
12%
Soft Tissue Sarcoma
100%
Tumor Necrosis
100%
Tumor Necrosis Factor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Limb Perfusion
100%
Melphalan
25%
Recurrence Risk
12%
Soft Tissue Sarcoma
100%
Tumor Necrosis
100%
Tumor Necrosis Factor
12%